COVID-19 and New-Onset Psychosis: A Comprehensive Review

L. Moccia*, G. D. Kotzalidis, G. Bartolucci, S. Ruggiero, L. Monti, M. Biscosi, B. Terenzi, O. M. Ferrara, M. Mazza, Marco Di Nicola, Delfina Janiri, A. Simonetti, E. Caroppo, L. Janiri, Gabriele Sani

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Psychosis is a multifactorial condition that typically involves delusions, hallucinations, and disorganized thought, speech or behavior. The observation of an association between infectious epidemics and acute psychosis dates back to the last century. Recently, concerns have been expressed regarding COVID-19 and the risk for the development of new-onset psychosis. This article reviewed the current evidence of a possible link between SARS-CoV-2 and risk of psychosis as an acute or post-infectious manifestation of COVID-19. We here discuss potential neurobiological and environmental factors as well as a number of challenges in ascribing a causal pathogenic relationship between SARS-CoV-2 infection and new-onset psychosis.
Lingua originaleInglese
pagine (da-a)104-N/A
RivistaJournal of Personalized Medicine
Volume13
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - 2023

All Science Journal Classification (ASJC) codes

  • Medicina (varie)

Keywords

  • bipolar disorder
  • delirium
  • inflammation
  • schizophrenia
  • side effects
  • viral infection

Fingerprint

Entra nei temi di ricerca di 'COVID-19 and New-Onset Psychosis: A Comprehensive Review'. Insieme formano una fingerprint unica.

Cita questo